Literature DB >> 19706228

Effect of quality of life impact and clinical severity on adherence to topical acne treatment.

Jerry K L Tan1, Madhan Balagurusamy, Karen Fung, Aditya K Gupta, D Richard Thomas, Sheetal Sapra, Charles Lynde, Yves Poulin, Wayne Gulliver, Rolf J Sebaldt.   

Abstract

BACKGROUND: Topical medications are the most commonly prescribed treatments for acne patients. However, adherence to these treatments and possible associations with clinical severity and quality of life (QoL) impact are unclear.
PURPOSE: We evaluated the association between sociodemographic factors, clinical severity, and QoL impact and adherence to topical acne treatments.
METHODS: This was an observational study of acne patients referred for usual care to community-based dermatologists. Adherence was assessed with questionnaires after 2 months of acne therapy. The associations of adherence with factors of interest were evaluated by chi-square analysis and Spearman rank correlation.
RESULTS: In 152 acne patients treated with topical medications, low adherence was observed in 26%, medium in 49%, and high in 24%. Age, gender, duration of acne, education level, third-party drug plan coverage, smoking history, recreational drug use, ingestion of alcohol, and number of prescribed topical agents were not significantly associated with adherence. Adherence was significantly positively correlated with QoL impact (r = .24, p = .003), with the role-emotional and self-perception domains having the highest correlations. In contrast, adherence was weakly negatively correlated with facial acne severity (r = -.16, p = .047). LIMITATIONS: This study focused on facial acne, and adherence was based on patient reporting.
CONCLUSIONS: Adherence to topical acne therapy increases with impact on QoL but decreases with increasing acne severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706228     DOI: 10.2310/7750.2009.08055

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  5 in total

1.  Management of acne: Canadian clinical practice guideline.

Authors:  Yuka Asai; Akerke Baibergenova; Maha Dutil; Shannon Humphrey; Peter Hull; Charles Lynde; Yves Poulin; Neil H Shear; Jerry Tan; John Toole; Catherine Zip
Journal:  CMAJ       Date:  2015-11-16       Impact factor: 8.262

2.  Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits.

Authors:  Chuck W Lynde; Anneke Andriessen; Benjamin Barankin; Gillian De Gannes; Wayne Gulliver; Richard Haber; Catherine McCuaig; Poonam Rajan; Sandra P Skotnicki; Richard Thomas; Jack Toole; Ron Vender
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

3.  Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate.

Authors:  B Sevimli Dikicier
Journal:  J Int Med Res       Date:  2019-05-24       Impact factor: 1.671

4.  Acne subject preference for pump over tube for dispensing fixed-dose combination adapalene 0.1%-benzoyl peroxide 2.5% gel.

Authors:  Maria J Rueda
Journal:  Dermatol Ther (Heidelb)       Date:  2014-06-12

5.  Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study.

Authors:  Timothy Myhill; Warwick Coulson; Paul Nixon; Simon Royal; Terry McCormack; Nabil Kerrouche
Journal:  Dermatol Ther (Heidelb)       Date:  2017-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.